Higher circulating tryptophan metabolites are associated with improved survival among patients with stage I-III colorectal cancer: results from the FOCUS consortium

Victoria Damerell; Stefanie Brezina; Jennifer Ose; Anne Geijsen; Arve Ulvik; Eline van Roekel; Andreana N. Holowatyj; Dieuwertje Kok; Fränzel van Duijnhoven; Christopher Li; Nina Habermann; Alexis B. Ulrich; Ellen Kampman; Matty Weijenberg; Andrea Gsur; Per M. Ueland; Martin Schneider; Cornelia M. Ulrich; Biljana Gigic

doi:10.1158/1538-7445.AM2023-1004

Higher circulating tryptophan metabolites are associated with improved survival among patients with stage I-III colorectal cancer: results from the FOCUS consortium

Victoria Damerell, Stefanie Brezina, Jennifer Ose, Anne Geijsen, Arve Ulvik, Eline van Roekel, Andreana N. Holowatyj, Dieuwertje Kok, Fränzel van Duijnhoven, Christopher Li, Nina Habermann, Alexis B. Ulrich, Ellen Kampman, Matty Weijenberg, Andrea Gsur, Per M. Ueland, Martin Schneider, Cornelia M. Ulrich, Biljana Gigic

Research output: Contribution to journal › Abstract › Academic

Original language	English
Article number	1004
Journal	Cancer Research
Volume	83
Issue number	7 Supplement
DOIs	https://doi.org/10.1158/1538-7445.AM2023-1004
Publication status	Published - 4 Apr 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1158/1538-7445.AM2023-1004Licence: Publisher

Cite this

Damerell, V., Brezina, S., Ose, J., Geijsen, A., Ulvik, A., van Roekel, E., Holowatyj, A. N., Kok, D., van Duijnhoven, F., Li, C., Habermann, N., Ulrich, A. B., Kampman, E., Weijenberg, M., Gsur, A., Ueland, P. M., Schneider, M., Ulrich, C. M., & Gigic, B. (2023). Higher circulating tryptophan metabolites are associated with improved survival among patients with stage I-III colorectal cancer: results from the FOCUS consortium. Cancer Research, 83(7 Supplement), Article 1004. https://doi.org/10.1158/1538-7445.AM2023-1004

@article{631c2f6362a643eea9960166bc18e7df,

title = "Higher circulating tryptophan metabolites are associated with improved survival among patients with stage I-III colorectal cancer: results from the FOCUS consortium",

author = "Victoria Damerell and Stefanie Brezina and Jennifer Ose and Anne Geijsen and Arve Ulvik and {van Roekel}, Eline and Holowatyj, {Andreana N.} and Dieuwertje Kok and {van Duijnhoven}, Fr{\"a}nzel and Christopher Li and Nina Habermann and Ulrich, {Alexis B.} and Ellen Kampman and Matty Weijenberg and Andrea Gsur and Ueland, {Per M.} and Martin Schneider and Ulrich, {Cornelia M.} and Biljana Gigic",

year = "2023",

month = apr,

day = "4",

doi = "10.1158/1538-7445.AM2023-1004",

language = "English",

volume = "83",

journal = "Cancer Research",

issn = "0008-5472",

publisher = "American Association for Cancer Research",

number = "7 Supplement",

}

Damerell, V, Brezina, S, Ose, J, Geijsen, A, Ulvik, A, van Roekel, E, Holowatyj, AN, Kok, D , van Duijnhoven, F, Li, C, Habermann, N, Ulrich, AB, Kampman, E, Weijenberg, M, Gsur, A, Ueland, PM, Schneider, M, Ulrich, CM & Gigic, B 2023, 'Higher circulating tryptophan metabolites are associated with improved survival among patients with stage I-III colorectal cancer: results from the FOCUS consortium', Cancer Research, vol. 83, no. 7 Supplement, 1004. https://doi.org/10.1158/1538-7445.AM2023-1004

TY - JOUR

T1 - Higher circulating tryptophan metabolites are associated with improved survival among patients with stage I-III colorectal cancer: results from the FOCUS consortium

AU - Damerell, Victoria

AU - Brezina, Stefanie

AU - Ose, Jennifer

AU - Geijsen, Anne

AU - Ulvik, Arve

AU - van Roekel, Eline

AU - Holowatyj, Andreana N.

AU - Kok, Dieuwertje

AU - van Duijnhoven, Fränzel

AU - Li, Christopher

AU - Habermann, Nina

AU - Ulrich, Alexis B.

AU - Kampman, Ellen

AU - Weijenberg, Matty

AU - Gsur, Andrea

AU - Ueland, Per M.

AU - Schneider, Martin

AU - Ulrich, Cornelia M.

AU - Gigic, Biljana

PY - 2023/4/4

Y1 - 2023/4/4

U2 - 10.1158/1538-7445.AM2023-1004

DO - 10.1158/1538-7445.AM2023-1004

M3 - Abstract

SN - 0008-5472

VL - 83

JO - Cancer Research

JF - Cancer Research

IS - 7 Supplement

M1 - 1004

ER -